Stocks
Amedisys (AMED) EBITDA margin US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 12.1% | 14.5% | 9.33% | 9.70% | 3.13% | 6.85% | ||
| Changes by years, y/y, % | +2pp | +2pp | -5pp | +0pp | -7pp | -21.4% | |||
Amedisys. EBITDA margin, %
Amedisys. EBITDA margin, changes, pp
Amedisys (AMED) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | FY2025Q2 | LTM ? | |||
| EBITDA margin, % | ? | 11.9% | 4.42% | 0.53% | 15.0% | 7.44% | 6.85% | |
| Changes by years, y/y, % | +21pp | -5pp | -7pp | -4pp | ||||
| Changes by quarters, q/q, % | +4pp | -7pp | -4pp | +14pp | -8pp | |||
